This study identifies MDM2 as a potential common E3 ligase for AR, AR-V7, and TM4SF3 in prostate cancer cells and suggests a novel mechanism for the mutual stabilization of TM4SF3 with AR or AR-V7 by disrupting the action of MDM2 on these proteins. Here, TSPAN8 is linked to prostate carcinoma.